Auris Medical Holding Stock Net Income
Auris Medical Holding fundamentals help investors to digest information that contributes to Auris Medical's financial success or failures. It also enables traders to predict the movement of Auris Stock. The fundamental analysis module provides a way to measure Auris Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auris Medical stock.
Auris |
Auris Medical Holding Company Net Income Analysis
Auris Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Auris Medical Net Income | (8.2 M) |
Most of Auris Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auris Medical Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Auris Medical Holding reported net income of (8.2 Million). This is 102.4% lower than that of the Healthcare sector and 111.71% lower than that of the Biotechnology industry. The net income for all United States stocks is 101.44% higher than that of the company.
Auris Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auris Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Auris Medical could also be used in its relative valuation, which is a method of valuing Auris Medical by comparing valuation metrics of similar companies.Auris Medical is currently under evaluation in net income category among related companies.
Auris Fundamentals
| Return On Equity | -71.91 | |||
| Return On Asset | -21.99 | |||
| Current Valuation | 32.76 M | |||
| Shares Outstanding | 12.87 M | |||
| Shares Owned By Insiders | 5.45 % | |||
| Shares Owned By Institutions | 5.34 % | |||
| Number Of Shares Shorted | 362.97 K | |||
| Price To Earning | (1.05) X | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 224.60 X | |||
| Revenue | 174.47 K | |||
| Gross Profit | 174.47 K | |||
| EBITDA | (5.26 M) | |||
| Net Income | (8.2 M) | |||
| Cash And Equivalents | 11.26 M | |||
| Cash Per Share | 0.88 X | |||
| Total Debt | 523.92 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 3.83 X | |||
| Book Value Per Share | 1.47 X | |||
| Cash Flow From Operations | (4.84 M) | |||
| Short Ratio | 0.15 X | |||
| Earnings Per Share | (1.49) X | |||
| Beta | 1.37 | |||
| Market Capitalization | 39.19 M | |||
| Total Asset | 41 M | |||
| Retained Earnings | (164.84 M) | |||
| Working Capital | 31 M | |||
| Current Asset | 39 M | |||
| Current Liabilities | 8 M | |||
| Z Score | 38.8 |
Pair Trading with Auris Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Auris Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Auris Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Auris Stock
If you are still planning to invest in Auris Medical Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Auris Medical's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |